Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02027961
Title Phase 1 Safety and Tolerability of MEDI4736 in Combination With Dabrafenib and Trametinib or With Trametinib Alone
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors MedImmune LLC
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | FRA | CAN

Facility Status City State Zip Country Details
Research Site Scottsdale Arizona 85258 United States Details
Research Site Los Angeles California 90095 United States Details
Research Site San Francisco California 94115 United States Details
Research Site Miami Beach Florida 33140 United States Details
Research Site Chicago Illinois 60611 United States Details
Research Site Boston Massachusetts 02114 United States Details
Research Site Saint Louis Missouri 63110 United States Details
Research Site Toronto Ontario M5G 2M9 Canada Details
Research Site Montreal Quebec H3A 1A1 Canada Details
Research Site Villejuif 94805 France Details
Research Site Napoli 80131 Italy Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field